2173. Activity of Ceftobiprole Against Enterococcus faecalis Clinical Isolates From the United States (2016–2020), Including Those From Difficult-to-Treat Infections

BACKGROUND: Ceftobiprole (BPR) is an advanced-generation cephalosporin that has in vitro and in vivo activity against clinically important Gram-positive organisms, including MRSA and Gram-negative organisms. While BPR does not have clinically relevant activity against Enterococcus faecium, BPR is ac...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendes, Rodrigo E, Duncan, Leonard R, Sader, Helio S, Smart, Jennifer, Jones, Mark E, Castanheira, Mariana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677393/
http://dx.doi.org/10.1093/ofid/ofad500.1795

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677393/
http://dx.doi.org/10.1093/ofid/ofad500.1795

Ejemplares similares